Clinical Trial Update: Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study [Phase 4]

View source ↗

Summary

Phase 4, controlled study evaluating methylphenidate for apathy in Alzheimer's disease. The results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Alzheimer's Disease, Apathy | Phase 4 | Status: COMPLETED | Results posted: 2015-11-20